Trial intelligence / Profile preview

Antenatal TRH in Threatened Premature Delivery

NCT00004778Phase 3Completed

Sponsor
National Center for Research Resources
Start
Aug 1993
Modality
Peptides, Recombinant Proteins and Enzymes
01

Overview

Phase 3, randomised, double-blind trial in respiratory distress syndrome (RDS) and chronic lung disease comparing TRH Group with Placebo Group (2 arms). Primary endpoints: Severity of initial lung disease and Occurrence of chronic lung disease. Started Aug 1993; status: completed.

02

Drugs

thyrotropin-releasing hormone
03

Conditions

respiratory distress syndrome (RDS)chronic lung disease

Beyond the preview

Go deeper on NCT00004778.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004778.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call